Skip to content

Clinical trials

Phase 3 Carcinoma, Hepatocellular trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 3 Country / region: Russia Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20082
20091
20101
20132
20151
20171
20185
20194

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer4
AstraZeneca3
Bristol-Myers Squibb3
Hoffmann-La Roche2
Merck Sharp & Dohme LLC2
Abbott1
Eisai Limited1
Exelixis1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular18
Liver Neoplasms6
Neoplasms4
Carcinoma2
Adenocarcinoma1
Digestive System Diseases1
Digestive System Neoplasms1
Liver Diseases1
Neoplasms by Histologic Type1
Neoplasms by Site1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.